Apitegromab's selective targeting of proMyostatin and latent myostatin addresses this directly, inhibiting only the muscle-relevant pathway while leaving vascular, hematopoietic, and reproductive TGF-beta signaling intact
This is due to certain experimental findings (Abo-Elenin et al., 2024
Nausea, vomiting, or dehydration can occur early in tirzepatide treatment and may temporarily raise blood pressure
Visible Batch Documentation A generic statement that a material is tested is not the same as publishing report-level evidence
0 peer-reviewed publications
If rapid weight loss is accompanied by significant declines in strength or energy, its worth reviewing medication dosage, diet, and exercise programming with a healthcare professional, says Enaz.